Phage Therapies: Lessons (Not) Learned from the "antibiotic Era"

The use of phages as therapeutic or prophylactic approaches is gaining increased interest amid the growing menace of antibiotic resistance. Phages, along with other new anti-infective strategies, are certainly welcome as much needed additions to the medicinal arsenal. However, we can easily make wit...

Full description

Bibliographic Details
Main Author: Amábile-Cuevas, C.F (Author)
Format: Article
Language:English
Published: Mary Ann Liebert Inc. 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 01899nam a2200313Ia 4500
001 10.1089-phage.2022.0001
008 220630s2022 CNT 000 0 und d
020 |a 26416530 (ISSN) 
245 1 0 |a Phage Therapies: Lessons (Not) Learned from the "antibiotic Era" 
260 0 |b Mary Ann Liebert Inc.  |c 2022 
520 3 |a The use of phages as therapeutic or prophylactic approaches is gaining increased interest amid the growing menace of antibiotic resistance. Phages, along with other new anti-infective strategies, are certainly welcome as much needed additions to the medicinal arsenal. However, we can easily make with phages the same mistakes we made with antibiotics, which caused the current resistance crisis. The oversimplification of the ecological role of antibiotics, neglecting ancient resistance and the role of horizontal gene transfer; the active search for wide spectrum, and the massive agricultural abuse; and, most importantly, the financial greed behind the development and use of antibiotics; these are all trends that are now visible in phage research. Should we bring phages to the same track that wasted antibiotics, we could be looking at a "postphage era"in our near future. © 2022, Mary Ann Liebert, Inc., publishers 2022. 
650 0 4 |a antibiotic resistance 
650 0 4 |a antibiotic resistance 
650 0 4 |a antibiotic therapy 
650 0 4 |a antimicrobial activity 
650 0 4 |a Article 
650 0 4 |a bacterial virulence 
650 0 4 |a bacteriophage 
650 0 4 |a herd immunity 
650 0 4 |a horizontal gene transfer 
650 0 4 |a horizontal gene transfer 
650 0 4 |a human 
650 0 4 |a infection risk 
650 0 4 |a nonhuman 
650 0 4 |a phage therapy 
650 0 4 |a phage therapy 
700 1 0 |a Amábile-Cuevas, C.F.  |e author 
773 |t PHAGE: Therapy, Applications, and Research 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1089/phage.2022.0001